Medical Devices

In a landmark decision, the DEA has rescheduled medical cannabis, unlocking scientific research, slashing industry taxes, and reshaping patient access.

A novel alpha-radiation therapy, Alpha DaRT, begins European trials, offering a new path for pancreatic cancer patients with no other treatment options.

With a fresh $22M investment and a $110M valuation, MINISH Technology is bringing its enamel-preserving, 'No-Drill' veneer system to the United States.

A medtech startup received a major NIH award to develop a wearable AI that predicts SUDEP, a deadly complication of epilepsy, offering new hope for patients.

Gentherm reports a record $394M first quarter, beating estimates as its transformational Modine deal progresses and it enters new medical and home markets.

With its CMO and CSO now both recipients of the AHA's top honor, Cardiovascular Clinical Sciences signals a rare concentration of elite expertise.

A new non-viral gene therapy targeting iron buildup in the eye has completed its Phase I trial, offering a potential new path for millions with dry AMD.

A novel RNA vaccine targeting hidden cancer antigens gets UK approval for a clinical trial, offering new hope for patients with hard-to-treat ovarian cancer.

With a physician shortage deepening across the US, two international medical schools just placed 97% of their graduates into residencies, many in underserved areas.

Days before the NFL Draft, Heisman winner Fernando Mendoza launches a major fund with a $500K pledge to fight the disease that affects his mother.

A new T-cell therapy, RPTR-1-201, enters clinical trials, offering hope for hard-to-treat solid tumors by targeting a shared, multi-cancer marker.

Winning top awards, China's Fosun Health unveils a bold strategy to become the premier gateway for Southeast Asian patients seeking advanced medical care.

As Materialise preps its Q1 2026 report, all eyes are on its booming medical unit to see if it can offset persistent industrial market weakness.

Breakthrough trial data shows a new device can keep donor hearts viable for longer, potentially expanding the organ pool and saving thousands on waitlists.

As its leaders vie for a top entrepreneurial award, a look at how GenScript quietly became an indispensable engine for global scientific breakthroughs.

A new AI-powered skin patch test for psoriasis just got a major US approval, promising to end costly trial-and-error treatments for millions of patients.

A breakthrough review validates harnessing neutrophils, the immune system's foot soldiers, for cancer, with a new therapy now heading to human trials.

New TempLock™ tech in the SherpaPak® system aims to keep donor hearts stable longer, potentially expanding the reach of life-saving transplants.

A novel, minimally invasive nerve ablation technology shows long-term promise for relieving severe pancreatic cancer pain, a major unmet medical need.

With over 47,000 members, Astiva Health's culturally tailored Medicare plans are outpacing rivals. Now, it's pivoting toward sustainable profit.